Watch this video on the BJS YouTube channel of vascular surgeons discussing the patients described in Boxes 1-3.
Common atherosclerotic conditions such as myocardial infarction and abdominal aortic aneurysm (AAA) are decreasing in prevalence as people smoke less and medical risk factor management improves. The incidence of peripheral vascular diseases, however, increases with age, so as populations grow older, particularly in affluent Western countries, vascular surgeons are confronted with increasing numbers of elderly patients 1 . The elderly with vascular disease have had time to acquire a variety of other problems, including type 2 diabetes and dementia, and their fitness for major interventions is often in doubt. Vascular surgery has evolved in recent years to meet this demand, and advances in endovascular technologies mean that even the frailest patients can usually be offered intervention. The question remains, however, which elderly patients derive benefit from which vascular interventions?
Information from vascular databases suggest that the rise in hospital admissions is driven by an increase in those aged over 75 years. Although there may be issues regarding case ascertainment as a result of more accurate coding over the past decade, in the UK admissions with acute limb ischaemia and thoracic aortic disease have risen in elderly patients 2 . The significant increase in the number of interventions for patients with thoracic aortic aneurysms has been driven mainly by developments in endovascular technology, but this does not seem to be the case for acute leg ischaemia, where endotechnologies (thrombolysis, percutaneous thrombectomy) do not yet seem to have widespread adoption 3 .
Vascular surgeons have always had to make decisions on selection for lifeor limb-preserving surgery No condition has been studied as widely as ruptured AAA (rAAA). Although the prevalence of rAAA is decreasing as a result of screening and reductions in smoking, it remains a fatal condition without treatment, and high risk even in those selected for intervention. No risk score reliably predicts patients for whom intervention is futile. Consequently, vascular surgeons frequently select patients for intervention on the basis of age alone. In a recent Delphi consensus study 4 there was agreement that patients aged over 85 years with rAAA should not be transferred from a district hospital to a vascular centre for assessment or surgery, owing to the expected poor outcome or limited potential to regain their former quality of life (Box 1).
Much of the elective activity of vascular surgeons involves risk reduction (preventing aneurysm rupture by elective repair; reducing stroke through carotid endarterectomy (CEA) or stenting). Intervention for nonruptured AAA is usually based on aortic diameter (over 5⋅4 cm) as a result of the randomized Small Aneurysm Trial. However, the risk : benefit ratio is different for a 65-year-old man with a large AAA detected by screening, and an 85-year-old man with a similar-sized AAA detected following regular surveillance. Decisions about
Box 1 Aorta
An 87-year-old woman lives in a residential home. An asymptomatic 7⋅0-cm infrarenal abdominal aortic aneurysm has been detected during an ultrasound examination of her urinary tract for recurrent infections. She has had a myocardial infarction. She can walk with the aid of a stick, but does not walk outside. What is the best elective care, and what should be done if she presents with a ruptured aneurysm? intervention may be aided by scoring systems, but almost all include advancing age as a variable. The Glasgow Aneurysm Score, for example, predicts mortality after both elective open aortic aneurysm surgery and endovascular aneurysm repair (EVAR), although patients aged over 75 years for open repair and over 86⋅5 years for EVAR are automatically deemed to be at high risk 5 . Unfortunately scoring systems are imprecise. Although useful for audit and research, they are of little benefit for individual decision-making.
Numerous publications have demonstrated good outcomes following vascular interventions in the elderly, although most have not reported on the remainder of the population turned down for intervention 6 . Population studies and large series consistently report inferior outcomes Vascular interventions in the elderly e17 from major vascular interventions in the elderly, even with sophisticated endovascular techniques. There appears to be wide variation in decisions to offer endovascular procedures to the elderly. A recent study 7 on selection for fenestrated aortic stent grafting showed little consistency. Elderly patients have been poorly represented in many large vascular randomized trials, and those that included them, such as the EVAR 2 Trial (EVAR versus best medical therapy in patients judged unfit for open repair), have failed to show any benefit of elective intervention 8 . Recovery is also prolonged after major vascular surgery in the elderly. In a study 9 published in 2001, despite a low perioperative mortality rate of 4 per cent for open AAA repair, after 34 months one-third of patients (36 per cent) were no longer living independently and nearly one in five said they would not undergo the operation again. Ensuring that elderly patients have the potential to return quickly to their former quality of life is essential. A 6-month convalescence might consume a large proportion of remaining life in an 85-year-old.
Carotid disease is somewhat different. The elderly may accept greater risk if the possible alternative is disabling stroke that might threaten independent existence. The current practice of CEA for symptomatic carotid disease differs considerably from that of the trial era (1980s), which generated most of the scientific evidence that underpins clinical practice. In the European Carotid Surgery Trial 10 , only 5⋅9 per cent of patients (176) were aged 75 years or more. A recent audit in the UK 11 suggests that patients currently offered intervention are much older, with more than 45 per cent having CEA or stenting being over 75 years old. Older patients have higher morbidity following CEA and stenting for both symptomatic and asymptomatic carotid disease 12 . Improved medical cardiovascular risk strategies call into question contemporary practice, especially in asymptomatic patients who benefit least from intervention (Box 2).
Box 2 Stroke/carotid
An 85-year-old man lives with his wife. He had a fall and developed some right leg and arm weakness 10 days ago. CT confirms a left cortical infarct and duplex imaging identifies a left internal carotid artery stenosis of 70 per cent. His wife says that he has become more forgetful over several months and frequently cannot remember things. The general practitioner confirms that she was investigating the patient for dementia.
As the burden of diabetes expands, elderly patients with diabetic foot ulceration are a common problem, with almost three-quarters having coexisting peripheral arterial disease 13 . Revascularization is not the only effective therapy, and a recent series 14 demonstrated alarming rates of dependence after revascularization for critical ischaemia, involving 21 per cent of patients at 12 months. Advanced wound care and comprehensive diabetes management may heal even the most ischaemic wounds. Swedish investigators 15 found that 50 per cent of patients with a mean age 78 years who had a diabetic foot ulcer and ischaemia (systolic toe pressure less than 45 mmHg and ankle pressure below 80 mmHg), and were either too frail to undergo revascularization or in whom it was not technically possible, healed their wounds either primarily or following a minor amputation. The only modifiable risk factor was the amount of tissue destruction at presentation. Vascular surgeons should develop improved pathways of care, with rapid comprehensive wound assessment and treatment to improve outcomes, especially in elderly frail patients.
Some elderly patients coming to the end of their lives present with vascular disease. Recognizing these individuals, such as those with acute limb ischaemia due to agonal thrombosis, is an important component of a caring service 16 . Palliative care is often the kindest and most positive option (Box 3).
Because the risks of intervention are higher, treatment of elderly patients with vascular disease may have to be modified. A full range of options should still be considered. Although a surgical approach may be best in selected patients, endovascular solutions are often better. Decisions should take into account existing and expected quality of life, dependency and family circumstances. Counselling the elderly and their families about vascular disease requires a sympathetic but realistic approach, but is worthwhile if good-quality life can be restored or prolonged by vascular intervention.
Box 3 Leg ischaemia
An 80-year-old man has advanced malignancy. He lives alone with daily visits from a carer. He has a 12-h history of a painful ischaemic foot and tender calf. Not in atrial fibrillation.
